CTXR
NASDAQ · Pharmaceuticals
Citius Pharmaceuticals Inc
$0.68
+0.04 (+6.28%)
Open$0.66
Previous Close$0.64
Day High$0.70
Day Low$0.64
52W High$2.19
52W Low$0.47
Volume—
Avg Volume1.11M
Market Cap18.81M
P/E Ratio—
EPS$-2.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+464.3% upside
Current
$0.68
$0.68
Target
$3.85
$3.85
$3.27
$3.85 avg
$6.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.36M | 3.56M | 3.14M |
| Net Income | 635.6K | 690.8K | 743.5K |
| Profit Margin | 18.9% | 19.4% | 23.7% |
| EBITDA | 1.24M | 1.20M | 1.26M |
| Free Cash Flow | 627.5K | 529.6K | 500.9K |
| Rev Growth | -2.5% | +1.7% | -0.7% |
| Debt/Equity | 1.45 | 1.39 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |